Renal biomarkers for the initiation of renal replacement therapy—is this the future?

Acute kidney injury (AKI) is a common complication in critically ill patients (1) affecting approximately 57.3% of all patients in the intensive care unit (ICU) and is associated with a high morbidity and mortality (2).